预测早期肺腺癌的潜在治疗标和小分子药物
Yongxin Yu1, Lingchen Li1, Bangyu Luo1
1Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
概括
研究人员确定了关键基因和一种药物Aminopurvalanol A,用于早期肺腺癌 (LUAD) 检测和治疗. 这项研究提供了新的生物标志物和肺癌管理的潜在治疗方法.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 分子生物学分子生物学
背景情况:
- 肺腺癌 (LUAD) 是癌症死亡的主要原因,目前的早期诊断方法需要改进.
- 有效的早期检测生物标志物和向治疗对于改善LUAD患者的治疗结果至关重要.
研究的目的:
- 通过生物信息学识别早期LUAD的新型诊断生物标志物.
- 根据已识别的生物标志物,发现和验证LUAD的潜在治疗剂.
主要方法:
- 利用基因表达总体 (GEO) 和癌症基因组图谱 (TCGA) 进行差异基因表达分析.
- 采用L1000FWD用于小分子药物鉴定,随后进行分子对接,体外和体内验证.
- 在LUAD中分析了10个具有生存意义的差异表达基因 (DEGs).
主要成果:
- 确定了六个关键基因 (TOP2A,CDH3,ASPM,CENPF,SLC2A1,PRC1) 作为早期LUAD检测的潜在生物标志物.
- 发现并验证了aminopurvalanol A作为LUAD的一种有前途的治疗药物.
- 在临床前模型中证明了Aminopurvalanol A的疗效和安全性.
结论:
- 这些已识别的基因作为 LUAD 早期诊断的有希望的生物标志物.
- 阿米诺普瓦拉诺A显示出作为安全有效的治疗剂的潜力.
- 这些发现为推进LUAD的临床管理提供了宝贵的见解.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K